Luisa Leal, APRN
Adult Health · Nashville, TNNPI 1720325830
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 19.6%. Among adult health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 837 payments — averaging $58.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$10K
- Amgen$8K
- Mannkind Corporation$8K
- Cequr Corporation$4K
- Ascensia Diabetes Care US Inc.$4K
- Zealand Pharma US, Inc.$4K
- plus $13K from 32 others
What the payments were for
- Consulting fees$2,8366%
- Speaking & faculty fees$20,15341%
- Travel & lodging$4,5589%
- Food & beverage$20,99443%
- Education$430%
- Gifts$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 51 | $9,535 |
| Amgen(2 entities) | 86 | $7,726 |
| Mannkind Corporation | 156 | $7,546 |
| Cequr Corporation | 5 | $3,621 |
| Ascensia Diabetes Care US Inc. | 11 | $3,607 |
| Zealand Pharma US, Inc. | 20 | $3,508 |
| AstraZeneca | 68 | $1,489 |
| Bayer | 38 | $1,390 |
| Medtronic | 21 | $1,352 |
| Novo Nordisk | 56 | $1,227 |
| Sanofi-aventis U.S. LLC | 38 | $828 |
| BETA Bionics, Inc. | 12 | $706 |
| Corcept Therapeutics | 18 | $696 |
| Lilly USA, LLC | 31 | $686 |
| AbbVie | 30 | $642 |
| Abbott | 41 | $601 |
| Xeris Pharmaceuticals, Inc. | 24 | $485 |
| Insulet Corporation | 14 | $402 |
| Boehringer Ingelheim | 17 | $399 |
| Novartis | 19 | $372 |
| Averitas Pharma Inc. | 15 | $361 |
| Radius Health, Inc. | 12 | $254 |
| Esperion Therapeutics, Inc. | 11 | $202 |
| Amneal Pharmaceuticals LLC | 8 | $188 |
| Merck | 7 | $118 |
| Sequel Med Tech, LLC | 3 | $93 |
| Exelixis Inc. | 1 | $87 |
| Tandem Diabetes Care, Inc. | 4 | $87 |
| Nevro Corp. | 4 | $81 |
| GRT US Holding, Inc. | 4 | $79 |
| E.r. Squibb & Sons, L.L.C. | 2 | $60 |
| Globus Medical | 2 | $50 |
| GSK | 2 | $42 |
| Amphastar Pharmaceuticals, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $27 |
| IBSA Pharma Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$7,958
- AFREZZA$4,659
- CeQur Simplicity$3,621
- TEPEZZA$2,845
- V-GO DISPOSABLE INSULIN DELIVERY$1,819
- ZEGALOGUE$1,440
- iLet Bionic Pancreas$1,289
- MINIMED 780G$768
- DEXCOM G6 TRANSMITTER$724
- Kerendia$612
- Korlym$505
- V-GO$450
- EVENITY$264
- FARXIGA$230
- RYBELSUS$209
- EVERSENSE E3 SMART TRANSMITTER KIT$178
- EVERSENSE E3 SENSOR KIT - RETAIL$143
- iLet Insulin Infusion Kit Inset$141
- iLet Insulin Infusion Kit Contact Detach$141
- JARDIANCE$123
How this compares
$48,642 in reported general payments places this provider in the 95th percentile of 352 adult health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 206 | $272,383 |
| JardianceEmpagliflozin | 91 | $113,844 |
| AfrezzaInsulin Regular, Human | 17 | $74,869 |
| KerendiaFinerenone | 57 | $61,623 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 80 | $53,974 |
| MounjaroTirzepatide | 34 | $49,190 |
| Tresiba Flextouch U-100Insulin Degludec | 48 | $41,738 |
| JanuviaSitagliptin Phosphate | 41 | $40,176 |
| TrulicityDulaglutide | 23 | $38,714 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $37,553 |
| FarxigaDapagliflozin Propanediol | 35 | $33,926 |
| Repatha SureclickEvolocumab | 38 | $27,099 |
| V-Go 20Sub-Q Insulin Device, 20 Unit | 31 | $26,898 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 26 | $26,198 |
| V-Go 40Sub-Q Insulin Device, 40 Unit | 27 | $25,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $1,227 | $283,929257 claims |
| Boehringer IngelheimJardiance, Tradjenta, Trijardy Xr | $399 | $142,165127 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $686 | $106,501139 claims |
| Mannkind CorporationAfrezza | $7,546 | $74,86917 claims |
| MerckJanuvia, Janumet | $118 | $62,80657 claims |
| BayerKerendia | $1,390 | $61,62357 claims |
| AstraZenecaFarxiga | $1,489 | $33,92635 claims |
| AbbVieSynthroid | $642 | $11,073112 claims |
| Sanofi-aventis U.S. LLCAdmelog | $828 | $2,79714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 352 adult health providers in Tennessee.
Other adult health in Nashville
- Brenda BaxterNashville$246K
- Tamera PaceNashville$16K
- Rochell BurtonNashville$14K
- Nataly BaileyNashville$10K
- Meredith DonahueNashville$8K
- Chelsea CollinsNashville$7K
- Hailey ChristianNashville$6K
- Jessie GibsonNashville$5K
- Patricia HaeberleNashville$5K
- Mary BacigalupoNashville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.